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The biological arms race generally involves the rapid
co-evolution of anti-virus systems in host organisms
and of anti-anti-virus systems in their viral parasites.
The CRISPR-Cas system is an example of a prokaryotic
immune system in which such co-evolution occurs, as
was recently demonstrated by the characterization of
a set of viral anti-CRISPR proteins.archaea [3]. The CRISPR-Cas system acquires short
DNA sequences from invading genetic elements, andIntroduction
Viruses are mobile genetic elements that rely on infect-
ing cellular organisms (eukaryotes or prokaryotes) for
replication and proliferation. These viral invasions often
reduce the fitness of their host, sometimes leading to
host death. This potential threat generates a selective
pressure on host organisms to evolve systems that
neutralize viral infections. When a protective barrier is
successfully established, the pressure to survive is placed
back on the parasite. After the rapidly evolving virus has
found a way to counteract the defense barrier, the host
has to start all over again. The continuous development
and adjustment of appropriate infection and resistance
strategies results in a rapid co-evolution of viral offence
systems and host defense systems. Such a biological
arms race implies that never-ending evolution is re-
quired for both predator and prey to maintain a constant
fitness level; this situation has been described in evolu-
tionary biology as the Red Queen hypothesis [1, 2].
Interference systems and suppression of RNA
interference
To counteract invasions by pathogenic viruses, many
vertebrate animals possess adaptive immune systems
consisting of specific antibody proteins, whereas many
plants and invertebrate animals use RNA-guided RNA
interference (RNAi) systems that efficiently recognize
and neutralize invading RNA. Likewise, a range of differ-
ent defense systems to counteract viral attack have been* Correspondence: john.vanderoost@wur.nl
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stated.discovered in prokaryotes, both bacteria and archaea.
The best-characterized prokaryotic innate immune sys-
tem concerns restriction/modification (R/M) enzymes.
During the past decade, new classes of bacterial defense
systems have been discovered that are based on RNA or
DNA interference. A ground-breaking discovery has
been the elucidation of CRISPR-Cas (clusters of regularly
interspaced palindromic repeats and associated pro-
teins), an adaptive immunity system in bacteria and
stores them in CRISPR arrays in the host genome. Upon
an infection by a previously encountered intruder, the
CRISPR memory is expressed as small CRISPR RNAs
(crRNAs) that guide surveillance complexes to comple-
mentary invading nucleic acids, eventually resulting in
neutralization of the invasion. CRISPR-Cas systems are
classified either as Class-1 systems, which have multi-
subunit crRNA–effector complexes (e.g., Cascade and
CMR), or as Class-2 systems, which have single protein
crRNA–effector complexes (e.g., Cas9 and Cpf1) [4].
Many eukaryotic viruses — for example, plant and
insect viruses — carry suppressors of RNAi on their viral
genomes to sabotage the RNAi immune system (Fig. 1a).
The mechanisms that these suppressors employ are very
diverse, ranging from the inhibition of small interfering
RNA (siRNA) production, to the formation of unpro-
ductive siRNA, sequestering of host siRNA, interference
with host gene regulation, and direct inhibition or inacti-
vation of RNAi protein components [5–7].Suppression of restriction/modification systems
and anti-CRISPR proteins
Several bacteriophages encode small proteins that in-
hibit or modulate the activity of restriction and DNA
modification systems [8] (Fig. 1b). Proteins such as
DarA and DarB from bacteriophage P1 are co-injected
with phage DNA into Escherichia coli cells to protect
sensitive restriction sites immediately upon entry.
Bacteriophage T7 encodes the Ocr protein, the struc-
ture of which mimics double-stranded DNA, and se-
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Fig. 1 Virus-encoded inhibitors of antiviral defense systems. a RNA viruses that infect various plants, insects and mammals encode proteins that
inhibit essential proteins in the RNA interference pathway, such as Dicer and Argonaute (AGO), a subunit of the RNA-induced silencing complex
(RISC). Furthermore, these viruses may produce proteins that will mask double-stranded RNA (dsRNA) so that Dicer activity does not occur or that
will sequester any small interfering RNA (siRNA) molecules produced. b Bacteriophage P1 co-injects DarA and DarB to mask restriction sites in the
phage genome. Bacteriophage T7 encodes Ocr, which mimics the DNA phosphate backbone and sequesters both the EcoKI restriction enzyme
(R) and its corresponding methylase (M). Bacteriophage Lambda encodes Ral, which hyperactivates the DNA methylase to protect phage DNA
before it can be restricted. c Anti-CRISPR proteins encoded by Pseudomonas prophages (AcrF1–AcrF3) bind CRISPR-RNA–effector complexes and
the nuclease Cas3 to prevent them from binding and cleaving target dsDNAs
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ploys a strategy of producing a protein called Ral that
activates the host’s DNA methylase to provide rapid pro-
tection from restriction.
Recently, dedicated viral proteins have been identified
that suppress CRISPR immunity (reviewed by Wieden-
heft [6]). Analyses of Pseudomonas aeruginosa-specific
phages have resulted in the identification of a range of
anti-CRISPR (Acr) protein variants [9–11]. Acr proteins
were initially discovered by analysis of Pseudomonas
strains that contain prophages in their chromosome.
Although most of these lysogenic strains have a func-
tional Type I-F CRISPR-Cas system (and thus are phage
resistant), some of these systems appeared to be inactive,
even in the presence of phage-targeting spacers. Molecu-
lar analyses of the inactive strains revealed a number of
small phage-encoded proteins that were responsible for
the observed phage-sensitive phenotype [9]. In a recent
follow-up study, it was demonstrated that three selected
Acr proteins inhibit the Type I-F CRISPR-Cas system
through different mechanisms (Fig. 1c): two suppressors
bind to different subunits of the Cascade-like complex
to block target DNA binding, whereas the third Acr
binds the Cas3 protein to prevent nuclease-helicase ac-
tivity that is required for target DNA degradation [10].
The tested Acr proteins are highly specific for the
Pseudomonas I-F system; no suppression was observedin the E. coli I-F system or in the Pseudomonas I-E system.
A separate study [11] revealed that some of the Pseudo-
monas prophages that possess I-F suppressor genes also
encode small suppressor proteins that specifically target
the Pseudomonas I-E system, but not the E. coli Type I-E
system.
Outlook
It is expected that all essential steps of antiviral defense
systems are potential targets for dedicated viral inhibitors,
as this will provide selective advantage for the virus. To
date, viral suppressors have been discovered for only two
CRISPR-Cas subtypes, but specific phage-encoded inhibi-
tors most probably exist for all other CRISPR systems as
well. This constant huge pressure on CRISPR-Cas systems
is an important driving force that would explain their
exceptional mutation rates. This rapid evolution is the
only way to keep the Red Queen running.
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